-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
67449107078
-
Analysis and estimates of the attributable risk for environmental and genetic risk factors in gastric cancer in a Chinese population
-
Shen X, Zhang J, Yan Y, Yang Y, Fu G, Pu Y. Analysis and estimates of the attributable risk for environmental and genetic risk factors in gastric cancer in a Chinese population. J oxicol Environ Health A 2009; 72: 759-766
-
(2009)
J Oxicol Environ Health A
, vol.72
, pp. 759-766
-
-
Shen, X.1
Zhang, J.2
Yan, Y.3
Yang, Y.4
Fu, G.5
Pu, Y.6
-
3
-
-
0026043230
-
New developments in the treatment of gastric carcinoma
-
Wilke H, Preusser P, Fink U, Achterrath W, Mayer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR, Gerlings H. New developments in the treatment of gastric carcinoma. Cancer Treat Res 1991; 55: 363-373
-
(1991)
Cancer Treat Res
, vol.55
, pp. 363-373
-
-
Wilke, H.1
Preusser, P.2
Fink, U.3
Achterrath, W.4
Mayer, H.J.5
Stahl, M.6
Lenaz, L.7
Meyer, J.8
Siewert, J.R.9
Gerlings, H.10
-
5
-
-
4043102535
-
Treatment of localized gastric cancer
-
Macdonald JS. Treatment of localized gastric cancer. Semin Oncol 2004; 31: 566-573
-
(2004)
Semin Oncol
, vol.31
, pp. 566-573
-
-
Macdonald, J.S.1
-
6
-
-
0027217474
-
Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
-
Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41
-
(1993)
Cancer
, vol.72
, pp. 37-41
-
-
Murad, A.M.1
Santiago, F.F.2
Petroianu, A.3
Rocha, P.R.4
Rodrigues, M.A.5
Rausch, M.6
-
7
-
-
0028959887
-
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
-
Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995; 71: 587-591
-
(1995)
Br J Cancer
, vol.71
, pp. 587-591
-
-
Pyrhönen, S.1
Kuitunen, T.2
Nyandoto, P.3
Kouri, M.4
-
8
-
-
8044236424
-
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
-
Glimelius B, Ekström K, Hoffman K, Graf W, Sjödén PO, Haglund U, Svensson C, Enander LK, Linné T, Sellström H, Heuman R. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997; 8: 163-168
-
(1997)
Ann Oncol
, vol.8
, pp. 163-168
-
-
Glimelius, B.1
Ekström, K.2
Hoffman, K.3
Graf, W.4
Sjödén, P.O.5
Haglund, U.6
Svensson, C.7
Enander, L.K.8
Linné, T.9
Sellström, H.10
Heuman, R.11
-
9
-
-
0018387446
-
Promotion of microtubule assembly in vitro by taxol
-
Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667
-
(1979)
Nature
, vol.277
, pp. 665-667
-
-
Schiff, P.B.1
Fant, J.2
Horwitz, S.B.3
-
11
-
-
34548241326
-
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 Study Group
-
Ajani JA, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Awad L, Van Cutsem E. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group. J Clin Oncol 2007; 25: 3210-3216
-
(2007)
J Clin Oncol
, vol.25
, pp. 3210-3216
-
-
Ajani, J.A.1
Moiseyenko, V.M.2
Tjulandin, S.3
Majlis, A.4
Constenla, M.5
Boni, C.6
Rodrigues, A.7
Fodor, M.8
Chao, Y.9
Voznyi, E.10
Awad, L.11
van Cutsem, E.12
-
12
-
-
33750949065
-
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group
-
Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006; 24: 4991-4997
-
(2006)
J Clin Oncol
, vol.24
, pp. 4991-4997
-
-
van Cutsem, E.1
Moiseyenko, V.M.2
Tjulandin, S.3
Majlis, A.4
Constenla, M.5
Boni, C.6
Rodrigues, A.7
Fodor, M.8
Chao, Y.9
Voznyi, E.10
Risse, M.L.11
Ajani, J.A.12
-
13
-
-
36348949070
-
A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer
-
Im CK, Jeung HC, Rha SY, Yoo NC, Noh SH, Roh JK, Chung HC. A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. Cancer Chemother Pharmacol 2008; 61: 315-321
-
(2008)
Cancer Chemother Pharmacol
, vol.61
, pp. 315-321
-
-
Im, C.K.1
Jeung, H.C.2
Rha, S.Y.3
Yoo, N.C.4
Noh, S.H.5
Roh, J.K.6
Chung, H.C.7
-
14
-
-
0032948714
-
Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma
-
Kim YH, Shin SW, Kim BS, Kim JH, Kim JG, Mok YJ, Kim CS, Rhyu HS, Hyun JH, Kim JS. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer 1999; 85: 295-301
-
(1999)
Cancer
, vol.85
, pp. 295-301
-
-
Kim, Y.H.1
Shin, S.W.2
Kim, B.S.3
Kim, J.H.4
Kim, J.G.5
Mok, Y.J.6
Kim, C.S.7
Rhyu, H.S.8
Hyun, J.H.9
Kim, J.S.10
-
15
-
-
0033509601
-
Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: A novel, safe, and effective regimen
-
Murad AM, Petroianu A, Guimaraes RC, Aragao BC, Cabral LO, Scalabrini-Neto AO. Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe, and effective regimen. Am J Clin Oncol 1999; 22: 580-586
-
(1999)
Am J Clin Oncol
, vol.22
, pp. 580-586
-
-
Murad, A.M.1
Petroianu, A.2
Guimaraes, R.C.3
Aragao, B.C.4
Cabral, L.O.5
Scalabrini-Neto, A.O.6
-
16
-
-
0034154069
-
Docetaxel (Taxotere)-cisplatin (TC): An effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
-
Roth AD, Maibach R, Martinelli G, Fazio N, Aapro MS, Pagani O, Morant R, Borner MM, Herrmann R, Honegger H, Cavalli F, Alberto P, Castiglione M, Goldhirsch A. Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol 2000; 11: 301-306
-
(2000)
Ann Oncol
, vol.11
, pp. 301-306
-
-
Roth, A.D.1
Maibach, R.2
Martinelli, G.3
Fazio, N.4
Aapro, M.S.5
Pagani, O.6
Morant, R.7
Borner, M.M.8
Herrmann, R.9
Honegger, H.10
Cavalli, F.11
Alberto, P.12
Castiglione, M.13
Goldhirsch, A.14
-
17
-
-
25144444885
-
The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer: A multicenter phase II study
-
Shin SJ, Chun SH, Kim KO, Kim MK, Lee KH, Hyun MS, Bae SH, Ryoo HM, Do YR, Kwon KY, Song HS. The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer: a multicenter phase II study. Korean J Intern Med 2005; 20: 135-140
-
(2005)
Korean J Intern Med
, vol.20
, pp. 135-140
-
-
Shin, S.J.1
Chun, S.H.2
Kim, K.O.3
Kim, M.K.4
Lee, K.H.5
Hyun, M.S.6
Bae, S.H.7
Ryoo, H.M.8
Do, Y.R.9
Kwon, K.Y.10
Song, H.S.11
-
18
-
-
0036866047
-
Cellular and molecular aspects of drugs of the future: Oxaliplatin
-
Di Francesco AM, Ruggiero A, Riccardi R. Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci 2002; 59: 1914-1927
-
(2002)
Cell Mol Life Sci
, vol.59
, pp. 1914-1927
-
-
di Francesco, A.M.1
Ruggiero, A.2
Riccardi, R.3
-
19
-
-
0142163708
-
A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines
-
Eriguchi M, Nonaka Y, Yanagie H, Yoshizaki I, Takeda Y, Sekiguchi M. A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines. Biomed Pharmacother 2003; 57: 412-415
-
(2003)
Biomed Pharmacother
, vol.57
, pp. 412-415
-
-
Eriguchi, M.1
Nonaka, Y.2
Yanagie, H.3
Yoshizaki, I.4
Takeda, Y.5
Sekiguchi, M.6
-
20
-
-
0036893770
-
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients
-
Louvet C, André T, Tigaud JM, Gamelin E, Douillard JY, Brunet R, François E, Jacob JH, Levoir D, Taamma A, Rougier P, Cvitkovic E, de Gramont A. Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 2002; 20: 4543-4548
-
(2002)
J Clin Oncol
, vol.20
, pp. 4543-4548
-
-
Louvet, C.1
André, T.2
Tigaud, J.M.3
Gamelin, E.4
Douillard, J.Y.5
Brunet, R.6
François, E.7
Jacob, J.H.8
Levoir, D.9
Taamma, A.10
Rougier, P.11
Cvitkovic, E.12
de Gramont, A.13
-
21
-
-
1442307855
-
Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer
-
Al-Batran SE, Atmaca A, Hegewisch-Becker S, Jaeger D, Hahnfeld S, Rummel MJ, Seipelt G, Rost A, Orth J, Knuth A, Jaeger E. Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 2004; 22: 658-663
-
(2004)
J Clin Oncol
, vol.22
, pp. 658-663
-
-
Al-Batran, S.E.1
Atmaca, A.2
Hegewisch-Becker, S.3
Jaeger, D.4
Hahnfeld, S.5
Rummel, M.J.6
Seipelt, G.7
Rost, A.8
Orth, J.9
Knuth, A.10
Jaeger, E.11
-
22
-
-
4243135036
-
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
-
Chao Y, Yeh KH, Chang CJ, Chen LT, Chao TY, Wu MF, Chang CS, Chang JY, Chung CY, Kao WY, Hsieh RK, Cheng AL. Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer 2004; 91: 453-458
-
(2004)
Br J Cancer
, vol.91
, pp. 453-458
-
-
Chao, Y.1
Yeh, K.H.2
Chang, C.J.3
Chen, L.T.4
Chao, T.Y.5
Wu, M.F.6
Chang, C.S.7
Chang, J.Y.8
Chung, C.Y.9
Kao, W.Y.10
Hsieh, R.K.11
Cheng, A.L.12
-
23
-
-
23744457430
-
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX egimen) as first-line treatment in metastatic gastric cancer
-
Lordick F, Lorenzen S, Stollfuss J, Vehling-Kaiser U, Kullmann F, Hentrich M, Zumschlinge R, Dietzfelbinger H, Thoedtmann J, Hennig M, Seroneit T, Bredenkamp R, Duyster J, Peschel C. Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX egimen) as first-line treatment in metastatic gastric cancer. Br J Cancer 2005; 93: 190-194
-
(2005)
Br J Cancer
, vol.93
, pp. 190-194
-
-
Lordick, F.1
Lorenzen, S.2
Stollfuss, J.3
Vehling-Kaiser, U.4
Kullmann, F.5
Hentrich, M.6
Zumschlinge, R.7
Dietzfelbinger, H.8
Thoedtmann, J.9
Hennig, M.10
Seroneit, T.11
Bredenkamp, R.12
Duyster, J.13
Peschel, C.14
-
24
-
-
33746796828
-
Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)
-
Cavanna L, Artioli F, Codignola C, Lazzaro A, Rizzi A, Gamboni A, Rota L, Rodinò C, Boni F, Iop A, Zaniboni A. Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC). Am J Clin Oncol 2006; 29: 371-375
-
(2006)
Am J Clin Oncol
, vol.29
, pp. 371-375
-
-
Cavanna, L.1
Artioli, F.2
Codignola, C.3
Lazzaro, A.4
Rizzi, A.5
Gamboni, A.6
Rota, L.7
Rodinò, C.8
Boni, F.9
Iop, A.10
Zaniboni, A.11
-
25
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
van Glabbeke, M.8
van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
26
-
-
16644393211
-
Surgical management of gastric stump cancer: A report of 37 cases
-
Chen L, Tian H, Chen J, He ZG, Tao SF, Lokesh G, Peng SY. Surgical management of gastric stump cancer: a report of 37 cases. J Zhejiang Univ Sci B 2005; 6: 38-42
-
(2005)
J Zhejiang Univ Sci B
, vol.6
, pp. 38-42
-
-
Chen, L.1
Tian, H.2
Chen, J.3
He, Z.G.4
Tao, S.F.5
Lokesh, G.6
Peng, S.Y.7
-
27
-
-
23844525579
-
Adjuvant chemoradiation using 5-fluorouracil/ folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: Two cooperative phase II studies of the AIO/ARO/ ACO
-
Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle EC, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann JT, Bokemeyer C. Adjuvant chemoradiation using 5-fluorouracil/ folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ ACO. Ann Oncol 2005; 16: 1326-1333
-
(2005)
Ann Oncol
, vol.16
, pp. 1326-1333
-
-
Kollmannsberger, C.1
Budach, W.2
Stahl, M.3
Schleucher, N.4
Hehr, T.5
Wilke, H.6
Schleicher, J.7
Vanhoefer, U.8
Jehle, E.C.9
Oechsle, K.10
Trarbach, T.11
Boehlke, I.12
Kanz, L.13
Hartmann, J.T.14
Bokemeyer, C.15
-
28
-
-
4644274892
-
Clinical and experimental study of oxaliplatin in treating human gastric carcinoma
-
Lin WL, Li DG, Chen Q, Lu HM. Clinical and experimental study of oxaliplatin in treating human gastric carcinoma. World J Gastroenterol 2004; 10: 2911-2915
-
(2004)
World J Gastroenterol
, vol.10
, pp. 2911-2915
-
-
Lin, W.L.1
Li, D.G.2
Chen, Q.3
Lu, H.M.4
-
29
-
-
0026512446
-
A chronopharmacologic phase II clinical trial with 5- fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer
-
Lévi F, Misset JL, Brienza S, Adam R, Metzger G, Itzakhi M, Caussanel JP, Kunstlinger F, Lecouturier S, Descorps-Declère A. A chronopharmacologic phase II clinical trial with 5- fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer 1992; 69: 893-900
-
(1992)
Cancer
, vol.69
, pp. 893-900
-
-
Lévi, F.1
Misset, J.L.2
Brienza, S.3
Adam, R.4
Metzger, G.5
Itzakhi, M.6
Caussanel, J.P.7
Kunstlinger, F.8
Lecouturier, S.9
Descorps-Declère, A.10
-
30
-
-
0028036652
-
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
-
Lévi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzhaki M, Dogliotti L. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst 1994; 86: 1608-1617
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 1608-1617
-
-
Lévi, F.A.1
Zidani, R.2
Vannetzel, J.M.3
Perpoint, B.4
Focan, C.5
Faggiuolo, R.6
Chollet, P.7
Garufi, C.8
Itzhaki, M.9
Dogliotti, L.10
-
31
-
-
0033874892
-
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
-
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947
-
(2000)
J Clin Oncol
, vol.18
, pp. 2938-2947
-
-
de Gramont, A.1
Figer, A.2
Seymour, M.3
Homerin, M.4
Hmissi, A.5
Cassidy, J.6
Boni, C.7
Cortes-Funes, H.8
Cervantes, A.9
Freyer, G.10
Papamichael, D.11
le Bail, N.12
Louvet, C.13
Hendler, D.14
de Braud, F.15
Wilson, C.16
Morvan, F.17
Bonetti, A.18
-
32
-
-
21144476975
-
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
-
De Vita F, Orditura M, Matano E, Bianco R, Carlomagno C, Infusino S, Damiano V, Simeone E, Diadema MR, Lieto E, Castellano P, Pepe S, De Placido S, Galizia G, Di Martino N, Ciardiello F, Catalano G, Bianco AR. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer 2005; 92: 1644-1649
-
(2005)
Br J Cancer
, vol.92
, pp. 1644-1649
-
-
de Vita, F.1
Orditura, M.2
Matano, E.3
Bianco, R.4
Carlomagno, C.5
Infusino, S.6
Damiano, V.7
Simeone, E.8
Diadema, M.R.9
Lieto, E.10
Castellano, P.11
Pepe, S.12
de Placido, S.13
Galizia, G.14
di Martino, N.15
Ciardiello, F.16
Catalano, G.17
Bianco, A.R.18
-
33
-
-
34848927813
-
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: Results of a phase II trial
-
Lorenzen S, Hentrich M, Haberl C, Heinemann V, Schuster T, Seroneit T, Roethling N, Peschel C, Lordick F. Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Ann Oncol 2007; 18: 1673-1679
-
(2007)
Ann Oncol
, vol.18
, pp. 1673-1679
-
-
Lorenzen, S.1
Hentrich, M.2
Haberl, C.3
Heinemann, V.4
Schuster, T.5
Seroneit, T.6
Roethling, N.7
Peschel, C.8
Lordick, F.9
|